BPG is committed to discovery and dissemination of knowledge
Editorial
©The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Methodol. Sep 20, 2025; 15(3): 100534
Published online Sep 20, 2025. doi: 10.5662/wjm.v15.i3.100534
Gut virome and its emerging role in inflammatory bowel disease
Abdulqadir J Nashwan, Rahat Khatoon Khokhar
Rahat Khatoon Khokhar, Department of Medicine, People’s University of Medical and Health Sciences, Nawabshah 67450, Pakistan
Abdulqadir J Nashwan, Department of Nursing & Midwifery Research, Hamad Medical Corporation, Doha 3050, Qatar
Author contributions: Khokhar RK and Nashwan AJ were responsible for writing the draft and critically reviewing the literature.
Conflict-of-interest statement: All the authors declare that they have no conflict of interest.
Corresponding author: Abdulqadir J Nashwan, PhD, Researcher, Department of Nursing & Midwifery Research, Hamad Medical Corporation, Rayyan Road, Doha 3050, Qatar. anashwan@hamad.qa
Received: August 19, 2024
Revised: January 20, 2025
Accepted: February 6, 2025
Published online: September 20, 2025
Processing time: 199 Days and 4.7 Hours
Core Tip

Core Tip: Inflammatory bowel disease (IBD) is a chronic multifactorial inflammatory disease involving the gastrointestinal tract. The exact etiopathogenesis is unknown, but gut microbiome dysbiosis is believed to be a cornerstone in triggering disease progression. The gut virome forms a significant part of the microbiome and participates in health and disease conditions. Until 2015, researchers paid little attention to their role in IBD. Subsequently, numerous studies have followed this line of inquiry, using advanced techniques to clarify this role. Herein, we emphasize the viral populations in the gut and their predicted roles in the etiopathogenesis of IBD based on current studies.